These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9057777)

  • 21. [Bolus fibrinolytic therapy in acute myocardial infarction].
    Pinelli G; Urbinati S
    Ital Heart J Suppl; 2001 Dec; 2(12):1360-2. PubMed ID: 11838360
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thrombolytic therapy for pulmonary thromboembolism].
    Pankov KS
    Klin Med (Mosk); 2004; 82(10):4-8. PubMed ID: 15584590
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thrombolytic therapy in acute myocardial infarct].
    Bode C; Baumann H; von Hodenberg E; Kübler W
    Med Klin (Munich); 1992 Feb; 87(2):64-9. PubMed ID: 1542285
    [No Abstract]   [Full Text] [Related]  

  • 24. [Reteplase. A new thrombolytic agent in the treatment of acute myocardial infarction].
    Jurlander B; Grande P
    Ugeskr Laeger; 1998 Jun; 160(24):3577-80. PubMed ID: 9641050
    [No Abstract]   [Full Text] [Related]  

  • 25. Thrombolytic therapy.
    Goldhaber SZ
    Adv Intern Med; 1999; 44():311-25. PubMed ID: 9929714
    [No Abstract]   [Full Text] [Related]  

  • 26. Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein.
    Cugno M; Cicardi M; Colucci M; Bisiani G; Merlini PA; Spinola A; Paonessa R; Agostoni A
    Thromb Haemost; 1996 Aug; 76(2):234-8. PubMed ID: 8865537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombolysis (Consensus about post-myocardial infarction treatment)].
    Arq Bras Cardiol; 1995 Mar; 64(3):271-80. PubMed ID: 7487519
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombolytic therapy for acute myocardial infarction--round 2.
    Lancet; 1988 Mar; 1(8585):565-7. PubMed ID: 2894496
    [No Abstract]   [Full Text] [Related]  

  • 29. New clot busters threaten Genentech's tPA.
    Davidson S
    Nat Biotechnol; 1997 May; 15(5):405. PubMed ID: 9131608
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombolytic agents for acute evolving myocardial infarction: comparative effects.
    Sherry S
    Ration Drug Ther; 1987 Jan; 21(1):1-9. PubMed ID: 3112866
    [No Abstract]   [Full Text] [Related]  

  • 31. How should intravenous thrombolytic agents for acute myocardial infarction be selected?
    Topol EJ
    Cardiovasc Clin; 1990; 21(1):57-75; discussion 76-8. PubMed ID: 2143103
    [No Abstract]   [Full Text] [Related]  

  • 32. Reteplase: a new thrombolytic for the treatment of acute myocardial infarction.
    Wooster MB; Luzier AB
    Ann Pharmacother; 1999 Mar; 33(3):318-24. PubMed ID: 10200858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerations.
    Verstraete M
    Circulation; 1987 Aug; 76(2 Pt 2):II31-8. PubMed ID: 3111745
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of reteplase on hemostasis variables: analysis of fibrin specificity, relation to bleeding complications and coronary patency.
    Meierhenrich R; Carlsson J; Seifried E; Pfarr E; Smolarz A; Neuhaus KL; Tebbe U
    Int J Cardiol; 1998 Jun; 65(1):57-63. PubMed ID: 9699932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 36. Reteplase in acute myocardial infarction.
    Busti AJ; Marshall KS; Hooper JS
    JAMA; 2004 May; 291(20):2429-30; author reply 2430. PubMed ID: 15161887
    [No Abstract]   [Full Text] [Related]  

  • 37. Is the streptokinase responsible for the endothelial injury and the platelet activation during fibrinolytic therapy?
    Kolev K; Skopál J; Nagy Z; Machovich R
    J Intern Med; 2001 May; 249(5):475-6. PubMed ID: 11350572
    [No Abstract]   [Full Text] [Related]  

  • 38. Equivalence trials.
    Ware JH; Antman EM
    N Engl J Med; 1997 Oct; 337(16):1159-61. PubMed ID: 9329939
    [No Abstract]   [Full Text] [Related]  

  • 39. Biochemical and pharmacologic comparison of thrombolytic agents.
    Stringer KA
    Pharmacotherapy; 1996; 16(5 Pt 2):119S-126S. PubMed ID: 8888099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second-dose thrombolytic following myocardial infarction.
    Furniss SS; Millar RN; Commerford PJ
    S Afr Med J; 1997 Feb; 87(2):179, 182. PubMed ID: 9107231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.